Detalhe da pesquisa
1.
Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial.
Eur Heart J
; 41(30): 2848-2859, 2020 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385506
2.
Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial.
Europace
; 21(7): 1023-1030, 2019 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30848783
3.
Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.
JAMA Neurol
; 76(12): 1457-1465, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31479105
4.
Minimal clinically important difference in Parkinson's disease as assessed in pivotal trials of pramipexole extended release.
Parkinsons Dis
; 2014: 467131, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24800101